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S-Adenosyl-L-Methionine protects the probiotic
yeast, Saccharomyces boulardii, from acid-induced
cell death
Vincent Cascio1,2, Daniel Gittings1,3, Kristen Merloni1, Matthew Hurton1, David Laprade1,4 and Nicanor Austriaco OP1*
Abstract
Background: Saccharomyces boulardii is a probiotic yeast routinely used to prevent and to treat gastrointestinal
disorders, including the antibiotic-associated diarrhea caused by Clostridium difficile infections. However, only 1-3%
of the yeast administered orally is recovered alive in the feces suggesting that this yeast is unable to survive the
acidic environment of the gastrointestinal tract.
Results: We provide evidence that suggests that S. boulardii undergoes programmed cell death (PCD) in acidic
environments, which is accompanied by the generation of reactive oxygen species and the appearance of caspase-
like activity. To better understand the mechanism of cell death at the molecular level, we generated microarray
gene expression profiles of S. boulardii cells cultured in an acidic environment. Significantly, functional annotation
revealed that the up-regulated genes were significantly over-represented in cell death pathways Finally, we show
that S-adenosyl-L-methionine (AdoMet), a commercially available, FDA-approved dietary supplement, enhances the
viability of S. boulardii in acidic environments, most likely by preventing programmed cell death.
Conclusions: In toto, given the observation that many of the proven health benefits of S. boulardii are dependent
on cell viability, our data suggests that taking S. boulardii and AdoMet together may be a more effective treatment
for gastrointestinal disorders than taking the probiotic yeast alone.
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Background
Saccharomyces boulardii is a non-pathogenic yeast clas-
sified as a probiotic – a live microorganism which, when
administered in adequate amounts, confers a health
benefit on the host – by the World Health Organization
[1]. Available for sale in over 100 countries under the
brand name Florastor, this yeast has been prescribed for
over fifty years to help maintain the natural flora of the
gastrointestinal tract [2,3]. Florastor is also sold as an
alternative remedy for acute childhood diarrhea [4] and
traveller’s diarrhea [5]. Clinically, S. boulardii has been
prescribed to treat antibiotic-associated diarrhea (AAD)
linked to bacterial infections, especially the AAD associated
with Clostridium difficile, the cause of about a third of all
AAD cases [6-11]. Significantly, the effectiveness of
S. boulardii as a probiotic has been demonstrated in
numerous clinical trials in both pediatric and adult
patient populations [9,12-15].
Studies have shown that the therapeutic effect of
Saccharomyces boulardii can be attributed to the
organism’s ability to interfere with and to destroy
pathogenic toxins, to decrease bacterial adhesion to
intestinal epithelial cells, to preserve the cellular integrity
of the intestinal lining, and to restore the intestinal
microbiome when it is destroyed [12,16,17]. S. boulardii is
also able to modify the host’s immune response by
either acting as an immune stimulant or by reducing
pro-inflammatory responses [18].
Although several studies had suggested that S. boulardii is
indistinguishable from other strains of Saccharomyces cere-
visiae, the common baker’s yeast used in laboratories world-
wide [3,19,20], more recent work has shown that
S. boulardii has unique genetic, physiological, and metabolic
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properties that can be used to differentiate it as a subspecies
from S. cerevisiae [21,22]. For example, S. boulardii
grows best at 37°C and is able to tolerate low pH, while
S. cerevisiae prefers cooler temperatures around 30°C
and cannot survive acidic environments [22,23]. These
phenotypic differences could explain both why S. boulardii
can persist in the gnotobiotic mouse models (10d) while
S. cerevisiae cannot (<1d) [24,25]. Furthermore, the
phenotypic differences may also explain why S. boulardii
can act as a probiotic, while S. cerevisiae cannot.
In order to benefit the host, probiotics given orally
must not only survive the initial transit through the
stomach, but also must be able to persist in the intestine
[26]. Studies have reported that only between 1-3% of
live yeast is recovered in human feces after oral adminis-
tration [27,28], as the acidic conditions disrupt cell wall
function and cause morphological alterations, leading to
cell death [27,29]. However, the nature of this cell death
remains unclear.
Recent studies with Saccharomyces cerevisiae have
shown that this budding yeast is able to undergo
programmed cell death (PCD) that is associated with
characteristic cell markers reminiscent of apoptosis in
mammalian cells including the accumulation of reactive
oxygen species (ROS), the condensation of chromatin, the
fragmentation of the nucleus, the degradation of DNA,
and the activation of caspase-like enzymatic activities [30].
Numerous external stimuli can induce PCD in yeast
including hydrogen peroxide, acetic acid, ethanol, high salt,
UV irradiation, and heat stress, among others [31-33].
Significantly, one study has shown that S. cerevisiae cells
undergo apoptotic cell death in acidic environments [34].
PCD has also been linked to intrinsic processes including
colony differentiation, replicative and chronological aging,
and failed mating events [35-39]. Finally, the process of
yeast programmed cell death is mediated by genes that
have orthologs that have been implicated in mammalian
apoptosis [40].
In this paper we provide evidence that suggests that
Saccharomyces boulardii, when cultured in either
ethanol, acetic acid, or hydrocholoric acid, dies with the
fragmentation of mitochondria, the production of reactive
oxygen species, and the activation of caspase-like enzymatic
activity, three hallmarks of PCD in Saccharomyces
cerevisiae. Moreover, we show that S-adenosyl-L-methio-
nine (AdoMet), a commercially available dietary supple-
ment, enhances the viability of S. boulardii in acidic
environments, most likely by preventing programmed cell
death. In toto, given the observation that many of the
proven health benefits of S. boulardii are dependent on
cell viability, our data suggests that taking S. boulardii
and AdoMet together may be a more effective treatment
for gastrointestinal disorders than taking the probiotic
yeast alone.
Methods
Yeast strains, plasmids, and growth conditions
All experiments were done with isogenic Saccharomyces
cerevisiae strains in the W303-1B background (MATα
ade2, his3, leu2, trp1, ura3, ssd1-d2), and with Saccharo-
myces boulardii (Florastor, Lot No. 538) obtained from
Biocodex, Inc. (San Bruno, CA). For all the experiments
described in this paper, cells were cultured and treated
using standard yeast protocols [41]. Unless noted other-
wise, all other drugs and reagents were purchased from
SIGMA-Aldrich.
Ethanol-induced cell death assay
Cells of the indicated strain and genotype were cultured in
rich YPD media overnight, resuspended in fresh media,
and allowed to reach exponential phase (an approximate
OD600 value of 0.2). They were then resuspended in water
or fresh media or in water or fresh media containing either
15% or 22% ethanol [33], and allowed to grow at 30°C for
the indicated times. Next, they were either serially diluted
onto YPD plates and cultured at 30°C for 2 days to test for
viability or treated with the appropriate stain for the indi-
cated test, and examined using a Zeiss LSM 700 Confocal
Laser Scanning Microscope. At least three independent
cultures were tested and compared. Statistical significance
was determined with the Student’s t-test.
Acetic acid-induced cell death assay
Cells of the indicated genotype were cultured in rich
YPD media overnight, resuspended in fresh media, and
allowed to reach exponential phase (an approximate
OD600 value of 0.2). They were then resuspended in
fresh media pH 3 or fresh media pH 3 containing
160mM acetic acid, allowed to grow at 30°C with shaking
for 2 hours. Next, they were treated with the appropriate
stain for the indicated test, and examined using a Zeiss
LSM 700 Confocal Laser Scanning Microscope.
Hydrochloric acid-induced cell death assay
Cells of the indicated genotype were cultured in rich
YPD media overnight, resuspended in fresh media, and
allowed to reach exponential phase (an approximate
OD600 value of 0.2). They were then resuspended in
water, water containing either 50 mM or 75 mM HCl,
water containing 50 mM HCl and 2 mM AdoMet, or
water containing 2 mM AdoMet alone. They were
allowed to sit at room temperature for 1.5 hours. Then,
they were either serially diluted onto YPD plates and
cultured at 30°C for 2 days to test for viability or treated
with the appropriate stain for the indicated test, and
examined using a Zeiss LSM 700 Confocal Laser Scan-
ning Microscope.
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Viability assay
Cells were grown overnight in rich YPD media at 30°C and
then diluted to a final concentration (an approximate
OD600 value of 0.2). For each strain, a series of 10-fold dilu-
tions was then prepared in water over a range of concentra-
tions from 10-1 to 10-5 relative to the initial culture. Spots
of 5 μl from each dilution series were then plated on the
indicated media and cultured at 30°C for 2 days. Individual
colonies were then counted and compared to the number
of colonies observed from an untreated culture serially
diluted at the beginning of the experiment. Several serial
dilutions for each culture were done to ensure that there
were enough colonies to count for statistical significance
and at least three independent cultures were tested and
compared. Statistical significance was determined with the
Student’s t-test. Note that after 3 hr, cells cultured in rich
media without any cell death inducing agents were able to
grow and to divide, hence the relative viability levels that
are greater than 100%.
In vivo detection of mitochondrial fragmentation, ROS
accumulation, and caspase activation
Mitochondrial fragmentation was detected in S. boulardii
cells using 10 nM Mitotracker Green (Molecular Probes),
according to the manufacturer’s specifications. Intracel-
lular ROS accumulation was examined after treatment
with 5 μg/ml of dihydrorhodamine 123 (DHR123;
Sigma Aldrich) [42]. Activated caspase-like activity was
detected in S. boulardii cells after treatment using a
FLICA apoptosis detection kit (ImmunoChemistry
Technologies, LLC) according to the manufacturer’s
specifications [43,44]. After exposure to reagents, S.
boulardii cells were harvested and examined using a
Zeiss LSM 700 Confocal Laser Scanning Microscope.
Fluorescence microscopy
Cells were grown to mid-log phase in selective media
and examined using a 63X oil-immersion objective and
a pinhole size of 1 Airy Unit using a Zeiss LSM 700
Laser Confocal Microscope Images were captured and
processed using the ZEN 2009 software package.
Microarray experiments: array design
Genomic sequences were obtained from the Saccharomyces
Genome Database (downloaded from www.yeastgenome.
org). These sequences were used to design a custom 8×15K
array using the Agilent eArray software (http://earray.
chem.agilent.com/). Each array had a minimum of 2
unique 60-mer probes designed against 6,612 open
reading frames encoded by S. cerevisiae. This resulted in
a total of 13,275 unique probes for each array, including
Agilent hybridization controls.
Microarray experiments: sample preparation, extraction,
and purification
S. boulardii cells were cultured in rich YPD media over-
night, resuspended in fresh media, and allowed to reach
exponential phase (an approximate OD600 value of 0.2).
They were then resuspended in 45 mL of either water,
for the control condition, or water containing 50 mM
HCl for the experimental condition. The total number of
cells in each experiment was 3 × 108, as measured with
a spectrophotometer. After a 1.5 hr incubation with shak-
ing at room temperature, the cells were washed with 1x
Figure 1 S. boulardii has decreased viability in ethanol, similar to S. cerevisiae. S. boulardii (Florastor) and S. cerevisiae (W303α) were cultured
in rich YPD media overnight and resuspended in fresh media and allowed to reach exponential phase. They were then resuspended in fresh media or
in fresh media containing 22% ethanol, allowed to grow at 30C for the indicated times, serially diluted onto YPD plates, and cultured at 30°C for 2
days. Viability was measured as percentage colony forming units. At least three independent cultures were tested and compared. Note that after 3 hr,
cells cultured in rich media without any cell death inducing agents were able to grow and to divide, hence the relative viability levels that are greater
than 100%. The differences in viabilities were deemed statistically significant by the Student’s t-test (p<0.05).
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Figure 2 (See legend on next page.)
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PBS, frozen in liquid nitrogen, and stored at −80°C. Total
RNA was then extracted using a RiboPure Yeast Kit
(Ambion) and purified of gDNA with Turbo DNase
(Ambion). RNA was assessed using a NanoDrop-2000c
spectrophotometer (Thermo Scientific) and Agilent
2100 bioanalyzer to determine RNA concentration,
purity, and integrity.
Microarray experiments: cDNA synthesis, labeling, and
hybridization
cDNA was generated from 10 μg aliquots of purified RNA
by first annealing hand-mixed random oligonucleotides
(pdN9, 6.3 μg) and oligo(dT)19V (8.3 μg) obtained from
IDT (Integrated DNA Technologies). First strand cDNA
synthesis was then performing using Super Script III
reverse transcriptase (Invitrogen) in a reaction containing
0.25 mM DTT and 0.5 mM total deoxynucleoside
triphosphates (amino-allyl-dUTP and deoxynucleoside
triphosphates) in a ratio of 3:2 aa-dUTP. After synthe-
sis for 3 hr at 42°C, the cDNA was hydrolyzed with 0.3
M NaOH and 0.03 M EDTA. The reaction was then
neutralized with 0.3 M HCl to pH 7.0. Following this,
cDNA was purified using a 25 ug capacity DNA Concentra-
tor and Cleanup Kit (Zymo), dried using a Speed-vac,
resuspended in ddH2O (2 μg cDNA per 9 μl water), and
stored at −80°C. Dye coupling was achieved by adding 1 μL
of 1.0 M NaHCO3 solution (pH 9.0) and 1.25 μL of either
Cy3 or Cy5 Amersham monoreative dye (GE Healthcare;
dissolved in DMSO) to each 9 μL aliquot of cDNA, then
incubating for 1 hr at room temperature in darkness.
Unincorporated dye was removed and the samples
purified using the Zymo cleanup kit. Dye incorporation
and cDNA yield were quantified using the NanoDrop-
2000c spectrophotometer on the microarray setting.
300 ng of the relevant Cy3- and Cy5-stained cDNAs
(control and experiment) were then pooled in a total
volume of 25 μL ddH2O and denatured at 95°C for 3
min. Following denaturation, 25 μL of 2x HiRPM gene
expression and hybridization buffer (Agilent) was
added to each sample. These cDNA solutions were
then applied to the microarray slide and incubated at
65°C for ~17 hr in a hybridization oven, as per the
manufacturer’s instructions. The slides were then
sequentially washed in a row of Agilent Wash Buffer I,
(See figure on previous page.)
Figure 2 Like S. cerevisiae, S. boulardii cells undergo programmed cell death in ethanol. S. Boulardii cells were cultured in rich YPD media
overnight and resuspended in fresh media and allowed to reach exponential phase. They were then resuspended either in water or fresh media
or in water or fresh media containing either 15% or 22% ethanol, and allowed to grow at 30C for the indicated times. (A) Mitochondrial
fragmentation was detected in cells cultured in 15% ethanol using 10 nM Mitotracker Green. (B) Intracellular ROS accumulation was detected in
cells cultured in 22% ethanol with 5 μg/ml of dihydrorhodamine 123. (C) Activated caspase-like enzymatic activity was detected in S. boulardii
cells cultured in 22% ethanol using a FLICA apoptosis detection kit according to the manufacturer’s specifications. At least three independent
cultures were tested and compared. The differences in staining patterns were deemed statistically significant by the Student’s t-test (p<0.05).
Figure 3 S. boulardii cells are more viable in 50 mM HCl than their S. cerevisiae counterparts. S. boulardii (Florastor) and S. cerevisiae
(W303α) were cultured in rich YPD media overnight and resuspended in fresh media and allowed to reach exponential phase. They were then
resuspended in water or water containing 50 mM HCl and allowed to grow at room temperature for the indicated times, serially diluted onto
YPD plates, and cultured at 30C for 2 days. At least three independent cultures were tested and compared. The differences in viabilities were
deemed statistically significant by the Student’s t-test (p<0.05).
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Agilent Wash Buffer II, and acetonitrile (Sigma), and
dried using Agilent drying and stabilization buffer.
Microarray data analysis and bioinformatics
Slides were scanned using an Axon 4000B scanner
(Molecular Devices) and fluorescence was quantified using
GENE Pix Pro 3.0 software (Molecular Devices). Data was
then normalized using the Goulphar transcriptome
platform (http://transcriptome.ens.fr/goulphar/). Dupli-
cate spots for each gene were averaged in Microsoft Excel,
and the results were confirmed using qPCR. The Cytos-
cape 2.8.3 (http://www.cytoscape.org/ download.php) plu-
gin BiNGO 2.44 was used to identify enriched biological
processes in differentially expressed genes after Benjamini
& Hochberg false discovery correction for multiple hypoth-
esis testing. Pairwise average linkage clustering analysis was
performed using the program Cluster and visualized using
Treeview [45].
Results and Discussion
Saccharomyces cerevisiae cells undergo programmed cell
death when they are cultured in media containing either
15% or 22% ethanol [33]. To determine if S. boulardii
also undergoes PCD, we began by comparing the viabil-
ities of both these strains in ethanol. While the W303α
strain shows almost 50% viability after three hours
Figure 4 S. boulardii undergoes programmed cell death in an acidic environment. S. boulardii (Florastor) was cultured in rich YPD media
overnight and resuspended in fresh media and allowed to reach exponential phase. They were then resuspended in water or water containing
75 mM HCl and allowed to grow at room temperature for 1.5 hr. (A) Intracellular ROS accumulation was examined after treatment with 5 μg/ml
of dihydrorhodamine 123. (B) Activated caspase-like activities were detected using a FLICA apoptosis detection kit according to the
manufacturer’s specifications. At least three independent cultures were tested and compared. The differences were deemed statistically significant
by the Student’s t-test (p<0.05).
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suspended in 22% ethanol, S. boulardii shows less than
10% viability after growth in the same media (Figure 1).
Our data suggests that S. boulardii is less viable in
ethanol than this common laboratory strain of S. cerevisiae,
which is not surprising given the adaptations of brewing
yeast, S. cerevisiae, that allow it to undergo fermentation
efficiently. (Note that after 3 hr, cells cultured in rich media
without any cell death inducing agents were able to grow
and to divide, hence the relative viability levels that are
greater than 100%).
Next, we examined the S. boulardii cells dying either
in 15% or in 22% ethanol for markers indicative of PCD
in yeast, including mitochondrial fragmentation, ROS
accumulation, and caspase-like enzyme activation. As
shown in Figure 2A, S. boulardii cells cultured in 15%
ethanol for 1.5 hr had fragmented mitochondria – punctate
fluorescence rather than the tubular fluorescence normally
seen in wildtype yeast cells – as revealed by MitoTracker
Green staining. Cells cultured in ethanol also accumulated
ROS (Figure 2B) and manifested a caspase-like activity as
measured by a FLICA assay (Figure 2C). Similar findings
were obtained with S. boulardii cells cultured in 160 mM
acetic acid (data not shown), another known inducer of
PCD in S. cerevisiae [46,47]. Together, these results suggest
that Saccharomyces boulardii, like Saccharomyces
cerevisiae, undergoes programmed cell death.
Studies have reported that only between 1-3% of live S.
boulardii yeast is recovered in human feces after oral
administration [27,28] as the acidic conditions disrupt
cell wall function and cause morphological alterations
that lead to cell death [27,29]. However, the nature of
this cell death in acidic environments remains unclear.
To determine the type of cell death experienced by S.
boulardii cells in an acidic environment, we began by
determining the viability of S. boulardii in low pH
conditions. Our results show that S. boulardii cells have
an increased viability in acidic conditions as compared
to their S. cerevisiae counterpart. After six hours in
50 mM HCl media, W303α cells showed almost no via-
bility, while S. boulardii cells were more than 70% viable
(Figure 3). This confirms the findings of others who have
shown that S. boulardii cells are more resistant to acidic
conditions than their S. cerevisiae cousins [21].
To determine if the S. boulardii cells were undergoing
PCD in the acidic environment, we repeated our cell
death assays with cells cultured in 75 mM HCl (pH 1.5),
a scenario that mimics the conditions in the stomach
[48]. DHR staining revealed that 92% of the S. boulardii
cells cultured in an acidic environment contained ROS
as compared to cells grown in rich YPD media
(Figure 4A). FLICA staining also showed that 90% of the
S. boulardii cells in the HCl solution, but only 1% of the
control cell population had activated caspase-like activity
(Figure 4B).
Finally, to better understand the mechanism of cell
death at the molecular level, we generated microarray
gene expression profiles of S. boulardii cells cultured in
Figure 5 Functional classification/GO analysis of differentially transcribed genes in S. boulardii cells cultured in 50 mM HCl. Genes
showing 2-fold or greater increase (up-regulated) or decrease (down-regulated) in response to an acidic environment were grouped in functional
categories. Categories that are significantly enriched relative to the yeast proteome are marked (*: p<0.05; ***: p<0.0005).
Table 1 S. boulardii cell death genes differentially
expressed in an acidic environment
S. BOULARDII CELL DEATH GENES
DIFFERENTIALLY EXPRESSED IN AN ACIDIC ENVIRONMENT
MCD1 NMA111 NUC1 TAH18
ATP1 ATP2 ATP7 COR1 COX4
COX5A COX6 COX8 CYT1 INH1
OYE3 PIN3 POR1 QCR2 QCR6
QCR7 QCR8 QCR9 QCR1O RIP1
RNY1 SDH1 SDH2 SDH4 UBX6
Saccharomyces boulardii cell death genes showing 2-fold or greater decrease
(underlined) or increase (italics) in response to an acidic environment were
identified using the Cytoscape 2.8.3 plugin BiNGO 2.44 after Benjamini &
Hochberg false discovery correction for multiple hypothesis testing.
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an acidic environment. We found that a total of 947
genes were differentially expressed (log2 values greater
than 2 or less that −2) of which 470 were up-regulated
and 457 down-regulated (Additional file 1). Signifi-
cantly, functional annotation revealed that the up-
regulated genes were significantly (p<0.0005) over-
represented in cell death pathways (Figure 5; Table 1).
One of these up-regulated cell death genes, RNY1,
encodes a RNase T2 family member that is released
from the vacuole into the cytosol during oxidative
stress to promote yeast cell death [49]. Since the
vacuole is the organelle most responsible for pH
homeostasis in yeast [50], this may suggest that a similar
mechanism of cell death may be occurring in S. boulardii
cells cultured in an acidic environment. Finally, a signifi-
cant majority of the other up-regulated cell death genes
(80%) were ORFs involved in mitochondrial function, in-
cluding numerous genes encoding proteins involved in the
electron transport chain (Table 1). These microarray
results together with our characterization of the cell death
phenotype described above suggest that S. boulardii
cells undergo PCD when they are cultured in acidic condi-
tions similar to those found in the stomach.
Previously published work has shown that S-adenosyl-L-
methionine (AdoMet) protects S. cerevisiae from pro-
grammed cell death [34]. To determine if AdoMet is also
capable of rescuing S. boulardii from inducers that induce
PCD, we first suspended S. boulardii cells either in 22%
ethanol or in 22% ethanol containing 1 mM AdoMet, for 3
hours. We discovered that both S. cerevisiae and S. boular-
dii cells cultured in ethanol containing AdoMet had
higher viabilities than cells cultured in ethanol alone
(Figure 6A). These results suggest that AdoMet is also cap-
able of rescuing S. boulardii from programmed cell death.
Next, we wanted to determine if AdoMet could also
rescue S. boulardii cells undergoing HCl-induced
Figure 6 AdoMet protects S. boulardii from ethanol and HCl-Induced cell death. S. boulardii cells (Florastor) were cultured in rich YPD
media overnight and resuspended in fresh media and allowed to reach exponential phase. (A) They were then resuspended in fresh media, in
fresh media containing 22% ethanol, in fresh media containing 1 mM AdoMet, or in in fresh media containing 22% ethanol and 1 mM AdoMet
and allowed to grow at 30C for the indicated times. Viability was measured as percentage colony forming units. (B) Next, S. boulardii cells were
resuspended in water, water containing 75 mM HCl, water containing 75 mM HCl and 2 mM AdoMet, or water containing 2 mM AdoMet alone.
They were allowed to grow at room temperature for 1.5 hours. Viability was measured as percentage colony forming units. (C) Exponential phase
S. boulardii cells were resuspended in the indicated culture conditions and allowed to grow at room temperature for 1.5 hr. Intracellular ROS
accumulation was detected with 5 μg/ml of dihydrorhodamine 123. (D) Activated caspase-like enzymatic activity was detected after treatment
using a FLICA apoptosis detection kit according to the manufacturer’s specifications. At least three independent cultures were tested and
compared. The differences were deemed statistically significant by the Student’s t-test (p<0.05).
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programmed cell death. As shown in Figure 6B, the via-
bility of Florastor cells cultured in an acidic environment
was significantly enhanced in the presence of 2 mM
AdoMet. Next, we showed that 2 mM AdoMet
decreased both ROS generation (Figure 6C) and caspase
activation (Figure 6D) in S. boulardii cells cultured in 50
mM HCl suggesting that this supplement may enhance
cell viability by preventing programmed cell death.
Conclusions
Our study provides evidence that suggests that S. boulardii
cells undergo programmed cell death in response to stimuli
known to induce PCD in S. cerevisiae, including an acidic
environment. Significantly, we were also able to show that
the addition of AdoMet is able to decrease caspase
activity and ROS production while increasing viability
in S. boulardii cells treated with hydrochloric acid.
Clinically, these results suggest that taking AdoMet — a
commercially available and FDA approved dietary supple-
ment — with S. boulardii could be useful in increasing the
viability of the yeast during its passage through the
acidic environment of the stomach. This should
improve its effectiveness both as a probiotic and as a
treatment for diarrhea.
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accession number, GSE43271.
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